Angiotensinkonverterende enzym efter AMI

C T Torp-Pedersen; L Køber; Trandolapril Cardiac Evaluation Study Group

Angiotensinkonverterende enzym efter AMI

Translated title of the contribution: Angiotensin-converting enzyme inhibitors after AMI

C T Torp-Pedersen, L Køber, Trandolapril Cardiac Evaluation Study Group

Abstract

The purpose of this study was to calculate the improvement in life expectancy by treating patients with left ventricular dysfunction after a myocardial infarction with an ACE inhibitor. Life expectancy was estimated as median lifetime and follow up in the TRACE study was prolonged until median lifetime could be calculated in both treatment groups. Median lifetime was reached in the placebo group after 4.6 years. In the trandolapril group median lifetime was increased by 15.3 months or 27% (7-51%). We conclude that the increase in lifetime by treatment of patients with left ventricular dysfunction after a myocardial infarction is substantial.
Udgivelsesdato: 2001-Jan-1

Translated title of the contribution	Angiotensin-converting enzyme inhibitors after AMI
Original language	Danish
Journal	Ugeskrift for læger
Volume	163
Issue number	1
Pages (from-to)	32-5
Number of pages	3
ISSN	0041-5782
Publication status	Published - 2001

Cite this

@article{e7e582c0119d11df803f000ea68e967b,

title = "Angiotensinkonverterende enzym efter AMI",

abstract = "The purpose of this study was to calculate the improvement in life expectancy by treating patients with left ventricular dysfunction after a myocardial infarction with an ACE inhibitor. Life expectancy was estimated as median lifetime and follow up in the TRACE study was prolonged until median lifetime could be calculated in both treatment groups. Median lifetime was reached in the placebo group after 4.6 years. In the trandolapril group median lifetime was increased by 15.3 months or 27% (7-51%). We conclude that the increase in lifetime by treatment of patients with left ventricular dysfunction after a myocardial infarction is substantial. Udgivelsesdato: 2001-Jan-1",

author = "Torp-Pedersen, {C T} and L K{\o}ber and {Trandolapril Cardiac Evaluation Study Group}",

note = "Keywords: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Denmark; Humans; Indoles; Life Expectancy; Middle Aged; Myocardial Infarction; Prognosis",

year = "2001",

language = "Dansk",

volume = "163",

pages = "32--5",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1",

}

TY - JOUR

T1 - Angiotensinkonverterende enzym efter AMI

AU - Torp-Pedersen, C T

AU - Køber, L

AU - Trandolapril Cardiac Evaluation Study Group

N1 - Keywords: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Denmark; Humans; Indoles; Life Expectancy; Middle Aged; Myocardial Infarction; Prognosis

PY - 2001

Y1 - 2001

N2 - The purpose of this study was to calculate the improvement in life expectancy by treating patients with left ventricular dysfunction after a myocardial infarction with an ACE inhibitor. Life expectancy was estimated as median lifetime and follow up in the TRACE study was prolonged until median lifetime could be calculated in both treatment groups. Median lifetime was reached in the placebo group after 4.6 years. In the trandolapril group median lifetime was increased by 15.3 months or 27% (7-51%). We conclude that the increase in lifetime by treatment of patients with left ventricular dysfunction after a myocardial infarction is substantial. Udgivelsesdato: 2001-Jan-1

AB - The purpose of this study was to calculate the improvement in life expectancy by treating patients with left ventricular dysfunction after a myocardial infarction with an ACE inhibitor. Life expectancy was estimated as median lifetime and follow up in the TRACE study was prolonged until median lifetime could be calculated in both treatment groups. Median lifetime was reached in the placebo group after 4.6 years. In the trandolapril group median lifetime was increased by 15.3 months or 27% (7-51%). We conclude that the increase in lifetime by treatment of patients with left ventricular dysfunction after a myocardial infarction is substantial. Udgivelsesdato: 2001-Jan-1

M3 - Tidsskriftartikel

C2 - 11586670

SN - 0041-5782

VL - 163

SP - 32

EP - 35

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 1

ER -